Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2204327
Max Phase: Preclinical
Molecular Formula: C39H59N5O8
Molecular Weight: 725.93
Molecule Type: Small molecule
Associated Items:
ID: ALA2204327
Max Phase: Preclinical
Molecular Formula: C39H59N5O8
Molecular Weight: 725.93
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1CCC[C@H](CN2CCOCC2)OC(=O)[C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)N[C@@H]2CN3CCC2CC3)CO1
Standard InChI: InChI=1S/C39H59N5O8/c45-35-13-7-12-30(24-44-18-20-50-21-19-44)52-39(49)36(46)31(22-27-8-3-1-4-9-27)41-38(48)34(26-51-35)42-37(47)32(23-28-10-5-2-6-11-28)40-33-25-43-16-14-29(33)15-17-43/h2,5-6,10-11,27,29-34,36,40,46H,1,3-4,7-9,12-26H2,(H,41,48)(H,42,47)/t30-,31+,32+,33-,34+,36-/m1/s1
Standard InChI Key: KUQRLGWOANPHCW-OUOPBPENSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 725.93 | Molecular Weight (Monoisotopic): 725.4364 | AlogP: 1.55 | #Rotatable Bonds: 10 |
Polar Surface Area: 158.77 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.71 | CX Basic pKa: 8.37 | CX LogP: 2.38 | CX LogD: 1.28 |
Aromatic Rings: 1 | Heavy Atoms: 52 | QED Weighted: 0.26 | Np Likeness Score: 0.39 |
1. Marsault E, Peterson ML.. (2011) Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery., 54 (7): [PMID:21381769] [10.1021/jm1012374] |
Source(1):